Events

To Mark Our 10th Anniversary - AXIS Consulting will host Ireland's First Ever Patient Access Conference

To celebrate our 10th anniversary, AXIS Consulting will be hosting the First Ever Patient Access Conference in Ireland on Friday the 30th of September 2022.  

This event will be a wonderful opportunity to hear from thought leaders and industry experts on the journey of a new medicine to a patient in Ireland. The conference will bring together the key stakeholders who help create patient access to new and highly innovative medicines. 

This will be an important event for anyone who has a keen interest in Patient Access or is responsible for reimbursement applications to the Irish authorities. 

To register your interest in this event and keep up to date with the latest updates, please email rachel@axisconsulting.ie 

  • Friday 30th September 2022
  • In Person Event – Corrigan Hall, Royal College of Physicians Ireland, Dublin 2
  • 9.30am-4.30pm

AXIS Consulting will exhibit at ABPI 2022 Annual Conference -“Delivering the UK’s Life Sciences Vision”

AXIS Consulting is delighted to be attending and exhibiting at the upcoming annual conference of The Association of the British Pharmaceutical Industry (ABPI) “Delivering the UK’s Life Sciences Vision” being held at the BMA House, Tavistock Square London.

This event takes place on Thursday the 30th of June from 9.00 am – 5.00 pm and will cover all areas of the Vision, including building the UK’s science and research Infrastructure; creating an outstanding environment for life sciences across regulation, manufacturing, trade, and skills; and importantly delivering access to new medicines and technologies.

Members of our team including our Founder and CEO Brenda Dooley will be present at the event to connect with all in attendance and look forward to sharing our expert insight and more information about our services that support dual submissions to the SMC and NCPE over parallel timelines. As AXIS celebrates its 10th year in operations, the team are committed to being your trusted market access partner for Scotland, Ireland and BeNeLuxA.

  • Thursday 30th June 2022
  • In Person Meeting
  • 9.00 am – 5.00 pm

EUCOPE Pricing and Reimbursement/ Market Access Working Group Meeting - The Implications of the new IPHA and MFI framework agreements 2022-2025

In 2021, the new framework agreement regarding the supply and pricing of medicines for Ireland was published. These agreements between The Irish Pharmaceutical Healthcare Association (IPHA) Medicines for Ireland (MFI) and the state authorities comprising of the Department of Health (DOH), Department of Public Expenditure and Reform (DEPR) and the Health Service Executive (HSE) set the reimbursement terms and conditions for all new and existing medicines for the period 2021-2025.

At the EUCOPE Pricing and Reimbursement/ Market Access Working Group Meeting on Wednesday the 8th of June, Brenda Dooley, Chief Executive Officer and Cillian Copeland, Senior HTA Manager both of AXIS Consulting will share their perspective and insights on these agreements. Their presentation will focus on the implications for those working in Market Access in Ireland and will be of value to anyone who has an interest in or is responsible for making pricing and reimbursement applications to the Irish Authorities.

  • Wednesday 8th June 2022
  • Virtual Meeting
  • 3.00 pm – 5.00pm CET

AXIS Consulting Sponsors The PMI 2022 Pharma Summit

AXIS Consulting are proud to be sponsoring the Pharmaceutical Managers Institute Pharma Summit 2022 on the 19th of May. The Annual Summit will be held in Fitzpatrick Castle Hotel, Killiney and will be a celebration of the innovators and trailblazers at the very heart of the healthcare industry. 

Our team will be present at the event to connect with all in attendance and will be happy to provide insight into the reimbursement process in Ireland and share best practice gleaned from the successful experiences of AXIS over the past 10 years in Ireland and internationally. 

  • Thursday 19th May 2022
  • In Person Event – Fitzpatrick Castle Hotel, Killiney Hill Road, Killiney, Dublin
  • 9.00am-5.00pm

What do the new IPHA, and MFI agreements really mean for Market Access in Ireland?

As we are all aware new framework agreements on the supply and pricing of medicines for Ireland were published in late 2021. The agreements between The Irish Pharmaceutical Healthcare Association (IPHA), Medicines for Ireland (MFI) and the state authorities comprising the Department of Health (DOH), Department of Public Expenditure and Reform ( DEPR) and the Health Service Executive (HSE) set the reimbursement terms and conditions for all new and existing medicines for the period 2021 –2025.

At the PMI breakfast meeting on Wednesday, March 9th, Brenda Dooley, Chief Executive at AXIS along with her colleague Senior HTA Manager Cillian Copeland, will focus on the key implications for those of us working in Market Access in Ireland. This will be an important event for anyone who has an interest in or is responsible for making pricing and reimbursement applications to the Irish authorities.

  • Wednesday 9th March 2022
  • Virtual Event
  • 8.00am-9.00am GMT

EMIG Scotland Webinar

You are invited to attend the EMIG Scotland webinar, organised by AXIS consulting.
At the webinar on February 24th, you will hear from guest speaker Mr Colin Briggs, Chair, NHS Scotland Directors of Planning & Director of Strategic Planning, NHS Lothian. Also, guest speaker Ms Jane Browning, Acting Associate Director of Pharmacy (Specialist Services, Development and Innovation).
To register for this webinar please visit the EMIG Platform.  If you have not used the platform before, please contact jill.payne@emig.org.uk for a login.
  • Thursday 24th February 2022
  • Virtual Event
  • 12.00pm-1.15pm GMT

EMIG Market Access Meeting: Market access implications of the new Irish IPHA / HSE framework agreement

You are invited to attend a Market Access webinar with guest speakers from AXIS Consulting. You can find the agenda here.  Please feel free to forward to colleagues who may also be interested.As you may be aware a new framework agreement on the supply and pricing of medicines for Ireland was published on December 6th 2021.  This new agreement sets out the reimbursement terms and conditions for all new and existing medicines for the period October 1st 2021-September 30th 2025.At the webinar on February 10th, Brenda Dooley, AXIS CEO and her colleague Cillian Copeland, Senior HTA Manager will shine the spotlight on what’s new in this agreement and importantly for attendees, explore the key implications for pharmaceutical companies who are making pricing and reimbursement applications to the Irish authorities.
To include a Q & A session
To register for this webinar please visit the EMIG Platform.  If you have not used the platform before, please contact jill.payne@emig.org.uk for a log in.
  • Thursday 10th February 2022
  • Virtual Event
  • 12.00pm-1.00pm GMT

Market access implications of the new Irish IPHA / HSE framework agreement

As you will be aware a new framework agreement on the supply and pricing of medicines for Ireland was published on December 6th, 2021. This new agreement sets out the reimbursement terms and conditions for all new and existing medicines for the period October 1st, 2021 – 30th September 2025.

At the webinar, CEO Brenda Dooley along with  Cillian Copeland, HTA Manager, will shine the spotlight on what’s new in this agreement and tease out the key implications for pharmaceutical companies who are making pricing and reimbursement applications to the Irish authorities.

We are delighted to announce that Jim McGrath, Director of Commercial Policy at the Irish Pharmaceutical Healthcare Association (IPHA) will join the webinar as our guest presenter. Jim will speak about IPHA’s role in negotiating a new agreement with the other key stakeholders, the Department of Health, the Department of Public Expenditure and Reform and the Health Service Executive.

This free of charge event is for pharmaceutical company employees only. Places are limited so if you wish to attend, please book your place now by emailing Kavi Burke, Operations Manager: Kavi@axisconsulting.ie

  • Tuesday, January 25th, 2022
  • Virtual Event
  • 11:00am – 12.15pm GMT

AXIS Autumn Masterclass: An Update on Pricing & Reimbursement in Ireland

The half day masterclass will focus on updates in the Irish pricing & reimbursement landscape and cover tips for making robust reimbursement submissions to the NCPE as well as how to prepare for price negotiations/discussions with the HSE.
If you are working in market access and reimbursement in Ireland, this is an event not to be missed.

Attendance is free, numbers limited.

The biannual AXIS Masterclasses are well received by industry professionals as a source of up to the minute information on the Irish Market Access landscape.

Click Here for the full agenda!

This event is intended for industry professionals working for pharmaceutical and MedTech firms.

  • Thursday November 25th, 2021
  • Virtual Event
  • 9:00am – 12.30pm BST

EMIG Scotland Group

The final EMIG Scotland webinar will be held on the 23rd November 2021 and they have a packed agenda!

Welcome and Introductions Leslie Galloway, Chair EMIG

The impact of Covid 19 on NHS Scotland,Liz Preston, Director, Synaptik UK

The role of the Scottish Health Technologies Group (SHTG) in Decision making Ed Clifton, Unit Head, SHTG

Results from the EMIG Scotland member Survey Brenda Dooley, CEO, Axis Consulting Scotland, Managing Secretariat, EMIG Scotland

to include a Q & A session

You can register for the meeting via the EMIG Platform.  If you haven’t already registered for the Platform you can enter your email and click reset password to gain access and receive the option of changing your password. If  you have any problems please contact jill.payne@emig.org.uk

Biographies of our Speakers

Elizabeth Preston is an experienced healthcare professional with a varied clinical and managerial career in the NHS. She trained at Guy’s Hospital London and subsequently in neurosciences at Addenbrooke’s Hospital, Cambridge. She moved to Edinburgh from Manchester to take up a sister’s post in neurosurgery. She subsequently took up a management position in Neurosciences and from there gained an MBA from Edinburgh Napier University and an MSc in Advanced Leadership Practice from Harvard Business School / Edinburgh Napier University along with a Post Graduate Diploma in Health Economics from the University of Aberdeen.

Elizabeth has managed many services in NHS Lothian, but cancer services remain her passion. She was the Clinical Lead for the TCAT programme in the South East Scotland Cancer Network and has always been passionate about improving services for patients and supporting the staff to undertake change.

She is now a Director of Synaptik, which is a Healthcare Consultancy based in Dunfermline, providing organisational & personal development and coaching, along with supplementary staffing for Health Boards.

Ed Clifton is the Unit Head of the Scottish Health Technologies Group (SHTG). SHTG is a national health technology assessment (HTA) agency that provides evidence support and advice to NHS Scotland on the use of new and existing health technologies which are not medicines and which are likely to have significant implications for people’s care. Prior to his current role, Ed has gained over 10 years of experience working as an economist within NHS Scotland, most recently as a Senior Health Economist within Healthcare Improvement Scotland.

 

 

 

 

 

Brenda Dooley, Founder and Chief Executive, AXIS Consulting Ltd., is an expert market access strategist with 20+ years international biopharma industry experience. She established AXIS Consulting in 2012 and with over 80 bespoke reimbursement submissions now completed for the Irish authorities, AXIS Consulting has become the leading global provider of services to pharmaceutical companies seeking access for new medicines in Ireland.

A member of the Minerva International Health Economics Network, Brenda has established strategic links with providers of health economics services across the UK, EU, USA and Canada. Knowing that a customised approach is fundamentally important for successful submissions to national agencies, Brenda has led AXIS Consulting’s recent expansion of market access services to Scotland and BeNeLuxAI.

Brenda holds a BA (Hons) in Business, a Diploma (Hons) in Financial Management and a MSc (Hons) in Health Economics. A member of Ireland’s Institute of Directors, Brenda is also a member of the National University of Ireland, Galway’s Investment committee having previously been a member of the University’s Risk & Audit Committee.

  • Tuesday, November 23rd, 2021
  • Virtual
  • 11.00am-12.30pm

Pharma Managers Series - HSE Briefing

The PMI is delighted to welcome Paul Reid back to give their members an update on:

  • where the HSE is versus plan
  • how the HSE has coped during the Covid pandemic & cyber attack
  • update on Sláintecare
  • impact of Covid on other therapy areas & on the general healthcare budget
  • what the next 12 months holds

 

 

 

 

As event sponsors, AXIS Consulting will present key findings from research the team have recently conducted on the “In-between timeline” of the NCPE Assessment process on submitted HTAs.

 

 

 

 

 

Over the past two years, AXIS has assessed the timelines in between the NCPE published submissions dates to ascertain the average period of time involved in the process and whether that differs from particular medicines such as Cancer medicines. The findings will be helpful to all in understanding the time the various components of the process take and will be very useful information for companies in their HTA submissions.

 

 

 

 

  • Thursday, November 4th , 2021
  • Virtual
  • 8:00 am – 9:00 am

BeNeLuxAI: Recent Experiences & Important Learnings

Who should attend this event?

Clients of AXIS Consulting, members, affiliates and stakeholders of IPHA as well as EFPIA members in Belgium, Luxembourg, Netherlands & Austria are invited to attend this free webinar.

Why should you attend this event?

The aim of the BeNeLuxAI initiative is to ensure sustainable access and affordable use of innovative medicines for patients. Over recent years the BeNeLuxAI collaborative has completed joint HTA assessments for a number of medicines. It is therefore timely to consider the key developments within the group and hear of the learnings of this joint collaborative comprising Belgium, Netherlands, Luxembourg, Austria and Ireland.
In addition to covering developments at BeNeLuxAI and the role of the pharmaceutical industry group in such collaborations, this webinar also provides an opportunity to hear about important updates on the International Horizon Scanning Initiative.

  • Thursday September 23, 2021
  • Virtual Event
  • 10:00am – 12.00pm BST

March 19th & 24th 2021 AXIS Virtual Market Access Masterclass - Access to New Medicines in Ireland- What’s Changing?

  • Fri, March 19, 2021 & Wed, March 24, 2021
  • Virtual Event
  • 9:00am – 12.30pm BST

Are you a Market Access Strategist based in Ireland or the UK with responsibility for developing a reimbursement submission to the Irish HTA assessment agency, the NCPE? Do you find it challenging to keep up to date with all the challenges in the Irish market access landscape? Would you like to be updated on and understand key changes occurring in 2021? 

Don’t miss our Spring 2021 Virtual Market Access Masterclass, normally a one-day event, this year’s masterclass will take place online over two half days. The virtual masterclass will provide you with an excellent opportunity to really get behind the scenes of the Irish system, learn how to avoid common submission pitfalls and hear of successful outcomes to reimbursement applications in Ireland.

  • Fri, March 19, 2021 & Wed, March 24, 2021
  • 9:00am – 12:30pm BST
  • Virtual event
  • Book Now

EMIG Scotland Special Interest Group

Speakers: Dr Andrew Walker, Director Salus Alba and ex reviewer at Scottish Medicines Consortium & Brenda Dooley, Chief Executive, AXIS Consulting & Managing Secretariat, EMIG Scotland

Andrew will update members on recent and key developments at the SMC. He will present his assessment of SMC decisions in 2020 as well as looking at the impact of the PACE process on the reimbursement of Orphan Medicines in Scotland including their use of modifiers. Andrew will also highlight the route taken by a number of medicines in Scotland on their journey to reimbursement

Brenda will then present highlights from the Scottish Landscape Report written and published by AXIS Consulting and comment on differences in the routes being pursued in Ireland for the same drugs as Andrew has highlighted for the SMC.

to include a Q & A session

  • Thursday 18th March 2021
  • Virtual Event
  • 11:00 am – 12:00 pm

THE PMI - Pharma Managers Series – HSE Briefing - Sponsored by AXIS Consulting

  • Thursday, November 5th , 2020
  • Virtual Event
  • 10:00 am – 11:00 am

At the PMI’s meeting on November 5th, Paul Reid, CEO at the HSE will give members an update on the Irish Health Service Executive

Paul Reid, Chief Executive Officer – HSE 

In May 2019 Paul Reid was appointed as Chief Executive Officer of the Health Service Executive where he now leads over 117,000 dedicated staff who deliver a wide range of health services across Ireland. Paul is a passionate public servant whose vision for the health service is to focus on long term planning by implementing Sláintecare and delivering effective and safe services within available resources. He is committed to building confidence and trust in our health service by supporting staff to deliver quality patient care through a new model of integrated services.

Prior to taking up the position of CEO at the HSE , Paul was Chief Executive of Fingal County Council, one of the largest Local Authorities in the state. Under his leadership over the period 2014-2019, Fingal was the leading local authority in terms of social and private housing development. It also led the way in terms of attracting Foreign Direct Investment and job creation across all sectors, through active land management and working with National State Agencies.

Between 2011 and 2014, Paul worked as the Chief Operations Officer in the Department of Public Expenditure & Reform. He was responsible for leading a whole set of reforms across the public service. In this role he negotiated the Haddington Road Agreement, with the 26 Public Service Trade Unions, to reduce the public service pay bill by €1BN.

Paul holds a Masters in Business Administration from Trinity College and a BA in Human Resources and Industrial Relations from the National College Ireland.

As Irelands leading provider of Market Access and Reimbursement submission services, AXIS Consulting is delighted to sponsor the PMI event on Nov 5th at which Paul Reid, CEO of the HSE will give an update on current and future activities within our health service. AXIS will also contribute to the agenda highlighting our recent research findings on reimbursement timelines in Ireland and also speak to some practical considerations to increase the speed at which new innovative medicines reach Irish patients

 

This event is proudly sponsored by:
axis health care consulting logo

Book Now

18th & 23rd Sept 2020 Market Access Virtual Masterclass
- Reimbursement in Ireland (Part 1 & 2)

  • September 18th & 23rd, 2020
  • Online Virtual Masterclass
  • Fri, 18 Sep 2020, 09:00am – 12.15pm & Wed, 23 Sep 2020, 09.00am – 12:15pm BST

Do you struggle to understand the Market Access landscape in Ireland? Are you spending valuable time trying to navigate the submission pathway? Would some strategic signposting and ‘on the ground’ local knowledge save you time and money?

Join AXIS CEO Brenda Dooley and her expert team for their Market Access Virtual Masterclass on Reimbursement Applications in Ireland. Normally a one day event, this year’s masterclass will take place online over two half days in September.

The virtual masterclass will provide you with an excellent opportunity to really get behind the scenes of the Irish system, learn how to avoid common submission pitfalls and hear of successful outcomes to reimbursement applications in Ireland.

AGENDA
CONTACT US